James J Modera, PT in Geneva, NY - Physical Therapist

James J Modera, PT is a Physical Therapist based in Geneva, New York. James J Modera is licensed to practice in New York (license number 0088031) and his current practice location is 283 W North St, Geneva, New York. He can be reached at his office (for appointments etc.) via phone at (315) 789-0841.

NPI number for James J Modera is 1659473478 and his current mailing address is 283 W North St, Geneva, New York. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1659473478.

Contact Information

	James J Modera, PT
	283 W North St, Geneva, NY 14456-1530
	(315) 789-0841
	(315) 789-0330

Healthcare Provider's Profile

Full Name	James J Modera
Gender	Male
Speciality	Physical Therapist
Location	283 W North St, Geneva, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1659473478
Provider Enumeration Date: 09/02/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for James J Modera such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1659473478	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	0088031 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. James J Modera is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
James J Modera, PT 283 W North St, Geneva, NY 14456-1530 Ph: (315) 789-0841	James J Modera, PT 283 W North St, Geneva, NY 14456-1530 Ph: (315) 789-0841

News Archive

Digital versions of standard molecular biology tool to detect common tumor-associated mutation in CSF

Massachusetts General Hospital (MGH) researchers and their colleagues have used digital versions of a standard molecular biology tool to detect a common tumor-associated mutation in the cerebrospinal fluid (CSF) of patients with brain tumors. In their report being published in the open-access journal Molecular Therapy - Nucleic Acids, the investigators describe using advanced forms of the gene-amplification technology polymerase chain reaction (PCR) to analyze bits of RNA carried in membrane-covered sacs called extracellular vesicles for the presence of a tumor-associated mutation in a gene called IDH1.

Verizon grants will eanble heart attack patients to receive life-saving treatments more quickly

Heart attack patients can receive life-saving treatments more quickly thanks to $100,000 in grants from the Verizon Foundation to the Foundation of UMDNJ for a program that enables heart attack patients to bypass the emergency room and go directly to the cardiac catheterization laboratory at UMDNJ-The University Hospital.

Québec-Transplant: 371 persons benefited from transplant in 2010

Thanks to 119 deceased organ donors, 371 persons benefited from a transplant in 2010. Unfortunately, there were also 46 deaths among people on the waiting list (compared to 58 in 2009), many of which could have been avoided. As of December 31, 2010, 1,241 people were registered on the single waiting list managed by Québec-Transplant.

ACCP and FIRS honor World Cancer Day

During the 2010: The Year of the Lung campaign, the American College of Chest Physicians (ACCP) and other members of the Forum of International Respiratory Societies (FIRS) are honoring World Cancer Day, February 4, by elevating the awareness of lung cancer in terms of prevalence and prevention, as well as the amount of funding the disease receives for research in diagnosis and management.

Does fetal fibronectin testing change patient management in women at risk of preterm labour?

Hologic, Inc. has announced the publication of the first of its kind study evaluating the impact of fetal fibronectin (fFN) testing among both symptomatic and asymptomatic pregnant women at risk for preterm birth. The study, "Does fetal fibronectin testing change patient management in women at risk of preterm labour?" by researchers at King's College, London, England appears in the on-line version of the European Journal of Obstetrics & Gynecology and Reproductive Biology.

Physical Therapist in Geneva, NY

Dr. Michael Joseph Vanfleet, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 196 North St, Geneva, NY 14456 Phone: 315-787-4570
Dr. Jordyn E Mundy, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 196 North St, Geneva, NY 14456 Phone: 315-787-4570
Dr. Michael T Skelly, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 515 W Washington St, Geneva, NY 14456 Phone: 315-781-1010 Fax: 315-781-1722
Brooke A. Mawery, D.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 515 W Washington St, Geneva, NY 14456 Phone: 315-781-1010 Fax: 315-781-1722
Mackensi Shaw, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 283 W North St, Geneva, NY 14456 Phone: 315-789-0841
Tracey L. Yacuzzo, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 515 West Washington Street, Geneva, NY 14456 Phone: 315-781-1010 Fax: 315-781-1722
Timothy S. Rutan, D.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 515 W Washington St, Geneva, NY 14456 Phone: 315-781-0101 Fax: 315-781-1722

James J Modera, PT - Physical Therapist in Geneva, NY